“Bombshell” investigation into Endo Health

As we end 2024, ProPublica and The Philadelphia Inquirer published a bombshell investigation into Endo Health Solutions – prosecutors said it profited by “misrepresenting the safety of their opioid products and using reckless marketing tactics”. The case was delayed over a decade, reducing funds for its opioid victims.